Aswin G. Abraham

Edmonton, AB T6G1G1, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Immunotherapy and Stereotactic Body Radiation Treatment-An Overview of the Current Landscape of the Strategic Combination of Two Treatment Modalities to Achieve Better Therapeutic Outcomes.

Immunotherapy and Stereotactic Body Radiation Treatment-An Overview of the Current Landscape of the Strategic Combination of Two Treatment Modalities to Achieve Better Therapeutic Outcomes.

Journal: Cancers

Published: April 22, 2026

Combining External Beam Radiotherapy and Immunotherapy for the Treatment of Hepatocellular Carcinoma.

Combining External Beam Radiotherapy and Immunotherapy for the Treatment of Hepatocellular Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: March 02, 2026

Early Detection of Lung Cancer: A Review of Innovative Milestones and Techniques.

Early Detection of Lung Cancer: A Review of Innovative Milestones and Techniques.

Journal: Journal of clinical medicine

Published: September 25, 2025

Adjuvant radiotherapy alone, an effective treatment option for early-stage low- risk breast cancer in women over 50: results from a population based cohort study using a Canadian provincial database.

Adjuvant radiotherapy alone, an effective treatment option for early-stage low- risk breast cancer in women over 50: results from a population based cohort study using a Canadian provincial database.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 12, 2025

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.

Journal: Nature cancer

Published: December 04, 2024

Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT).

Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT).

Journal: Current oncology (Toronto, Ont.)

Published: July 16, 2024

A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy.

A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 05, 2023

Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.

Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.

Journal: International journal of radiation oncology, biology, physics

Published: January 30, 2023

Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation.

Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation.

Journal: American journal of clinical oncology

Published: September 15, 2022

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Journal: Nature genetics

Published: August 21, 2022

Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal Cancer.

Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: December 09, 2021

Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial.

Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial.

Journal: International journal of radiation oncology, biology, physics

Published: December 02, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026